Elanco Animal Health Incorporated
ELAN
Rang in aandelen
#1818
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Aandeelprijs
$23.62
Marktkapitalisatie
$11.79B
Verandering (1 dag)
0.32%
Verandering (1 jaar)
10.25%
Land
US
Handel Elanco Animal Health Incorporated (ELAN)
Categorie
Healthcare
EPS voor Elanco Animal Health Incorporated (ELAN)
EPS per June 2026 TTM: $-0.41
Volgens de laatste financiële rapporten en de aandelenkoers van Elanco Animal Health Incorporated is de huidige EPS van het bedrijf (TTM) $-0.41. Eind 2023 had het bedrijf een EPS van $-2.50, een stijging ten opzichte van de EPS van 2022 die $-0.15 bedroeg.
EPS-geschiedenis van Elanco Animal Health Incorporated van 2015 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-0.41 | -160.29% |
| 2024 | $0.68 | -127.20% |
| 2023 | $-2.50 | 1,566.67% |
| 2022 | $-0.15 | -84.54% |
| 2021 | $-0.97 | -23.62% |
| 2020 | $-1.27 | -805.56% |
| 2019 | $0.18 | -35.71% |
| 2018 | $0.28 | -132.18% |
| 2017 | $-0.87 | 569.23% |
| 2016 | $-0.13 | -77.97% |
| 2015 | $-0.59 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -235.68% |
IN
|
